| Literature DB >> 31482695 |
Neta Zilony-Hanin1,2, Michal Rosenberg3, Michal Richman4, Ronen Yehuda5, Hadas Schori1, Menachem Motiei1,2, Shai Rahimipour4, Alexander Groisman6, Ester Segal3,7, Orit Shefi1,2.
Abstract
Nerve growth factor (NGF) plays a vital role in reducing the loss of cholinergic neurons in Alzheimer's disease (AD). However, its delivery to the brain remains a challenge. Herein, NGF is loaded into degradable oxidized porous silicon (PSiO2 ) carriers, which are designed to carry and continuously release the protein over a 1 month period. The released NGF exhibits a substantial neuroprotective effect in differentiated rat pheochromocytoma PC12 cells against amyloid-beta (Aβ)-induced cytotoxicity, which is associated with Alzheimer's disease. Next, two potential localized administration routes of the porous carriers into murine brain are investigated: implantation of PSiO2 chips above the dura mater, and biolistic bombardment of PSiO2 microparticles through an opening in the skull using a pneumatic gene gun. The PSiO2 -implanted mice are monitored for a period of 8 weeks and no inflammation or adverse effects are observed. Subsequently, a successful biolistic delivery of these highly porous microparticles into a live-mouse brain is demonstrated for the first time. The bombarded microparticles are observed to penetrate the brain and reach a depth of 150 µm. These results pave the way for using degradable PSiO2 carriers as potential localized delivery systems for NGF to the brain.Entities:
Keywords: Alzheimer's disease; biolistics; brain; delivery; nerve growth factor; porous silicon
Mesh:
Substances:
Year: 2019 PMID: 31482695 DOI: 10.1002/smll.201904203
Source DB: PubMed Journal: Small ISSN: 1613-6810 Impact factor: 13.281